Literature DB >> 25980522

Free Fecal Immunochemical Test Disbursement in Eight Family Physician Offices.

Jeanette M Daly1, Barcey T Levy, Yinghui Xu.   

Abstract

Colorectal cancer (CRC) is the second leading cause of cancer death. CRC screening with a fecal immunochemical test (FIT) is important as occult blood may be detected. To offer Iowa Research Network members in family physician offices the opportunity to provide FITs at no charge to patients in need and determine how many of the tests would be handed out to patients and how many would be returned to the office. Eight family physician offices agreed to participate and 50 two-day FITs were provided, potentially providing 400 patients a CRC screening test. One hundred and eighty (45%) of the 400 FITs were handed out to patients. Of the 92 (51%) patients who returned at least one card, 77 (84%) had negative results, 13 (14%) were positive, and 2 (2 %) were indeterminate. Of 13 patients with a positive result, 11 (85%) had a follow-up colonoscopy. Providing 400 FITs at no charge to the offices was an expensive endeavor. Implementing this forced a change in office routine and the type of fecal occult blood test used. Less than half of the FITs were given out to patients and of those given out, about half of the patients returned a FIT. For those who returned FITs and had positive findings, 85% followed-up with a colonoscopy. Office nurses implementing the CRC screening need to be included in the planning of the type of fecal occult blood test used and receptive to the project.

Entities:  

Mesh:

Year:  2015        PMID: 25980522      PMCID: PMC4711770          DOI: 10.1007/s10900-015-0025-1

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  28 in total

1.  The Colorectal Cancer Control Program: partnering to increase population level screening.

Authors:  Djenaba A Joseph; Amy S DeGroff; Nikki S Hayes; Faye L Wong; Marcus Plescia
Journal:  Gastrointest Endosc       Date:  2011-03       Impact factor: 9.427

2.  The "Iowa get screened" colon cancer screening program.

Authors:  Barcey T Levy; Jeanette M Daly; Bruce Luxon; Mary L Merchant; Yinghui Xu; Carly E Levitz; Jason K Wilbur
Journal:  J Prim Care Community Health       Date:  2010-04-01

3.  Mailed fecal immunochemical tests plus educational materials to improve colon cancer screening rates in Iowa Research Network (IRENE) practices.

Authors:  Barcey T Levy; Jeanette M Daly; Yinghui Xu; John W Ely
Journal:  J Am Board Fam Med       Date:  2012 Jan-Feb       Impact factor: 2.657

4.  Effect of season and ambient temperature on outcome of guaiac-based faecal occult blood tests performed for colorectal cancer screening.

Authors:  J P Hunter; A Saratzis; P Froggatt; C Harmston
Journal:  Colorectal Dis       Date:  2012-09       Impact factor: 3.788

5.  Surveillance of screening-detected cancers (colon and rectum, breast, and cervix) - United States, 2004-2006.

Authors:  S Jane Henley; Jessica B King; Robert R German; Lisa C Richardson; Marcus Plescia
Journal:  MMWR Surveill Summ       Date:  2010-11-26

6.  A quantitative immunochemical fecal occult blood test for colorectal neoplasia.

Authors:  Zohar Levi; Paul Rozen; Rachel Hazazi; Alex Vilkin; Amal Waked; Eran Maoz; Shlomo Birkenfeld; Moshe Leshno; Yaron Niv
Journal:  Ann Intern Med       Date:  2007-02-20       Impact factor: 25.391

Review 7.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

Authors:  Bernard Levin; David A Lieberman; Beth McFarland; Kimberly S Andrews; Durado Brooks; John Bond; Chiranjeev Dash; Francis M Giardiello; Seth Glick; David Johnson; C Daniel Johnson; Theodore R Levin; Perry J Pickhardt; Douglas K Rex; Robert A Smith; Alan Thorson; Sidney J Winawer
Journal:  Gastroenterology       Date:  2008-02-08       Impact factor: 22.682

8.  False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening.

Authors:  Leo G M van Rossum; Anne F van Rijn; Martijn G H van Oijen; Paul Fockens; Robert J F Laheij; Andre L M Verbeek; Jan B M J Jansen; Evelien Dekker
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

9.  Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts.

Authors:  Laura C Seeff; Amy DeGroff; Djenaba A Joseph; Janet Royalty; Florence K L Tangka; Marion R Nadel; Marcus Plescia
Journal:  Cancer       Date:  2013-08-01       Impact factor: 6.860

10.  Colorectal Cancer Control Program grantees' use of evidence-based interventions.

Authors:  Peggy A Hannon; Annette E Maxwell; Cam Escoffery; Thuy Vu; Marlana Kohn; Jennifer Leeman; Michelle L Carvalho; Debbie J Pfeiffer; Andrea Dwyer; Maria E Fernandez; Sally W Vernon; Lily Liang; Amy DeGroff
Journal:  Am J Prev Med       Date:  2013-11       Impact factor: 5.043

View more
  1 in total

1.  Fecal Immunochemical Test as a Screening Method for Colorectal Cancer in University College Hospital Ibadan, Nigeria.

Authors:  Elizabeth O Labaeka; Achiaka E Irabor; David O Irabor
Journal:  JCO Glob Oncol       Date:  2020-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.